We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Parthenogenesis a Promising Source of Embryonic Stem Cells

By Biotechdaily staff writers
Posted on 07 May 2003
Researchers are experimenting with parthogenesis as a way to produce embryonic stem cells that could never become human beings and thereby avert the ethical concerns that have led to restrictions on embryonic stem cell research. More...
Their work was reported in the April 26, 2003, issue of New Scientist.

In parthenogenesis, an unfertilized egg keeps two sets of chromosomes and begins developing as if it had been fertilized. Some insects and reptiles can reproduce this way but in mammals, the resulting embryos die after a few days. So destroying those cells to obtain stem cells would not cause concern. Although the technique works well in mice and monkeys, prior attempts with human eggs have not done well.

Now, researchers have grown parthenogenetic human embryos to the blastocyst stage, at which stem cells can be obtained. Cells taken from one of the embryos survived for a few days, and were perhaps the first parthenogenetic human cells. The next step is to get the cell line to grow in culture indefinitely to obtain a stem cell line. In monkeys, such as cell line has been growing for over two years. Analysis suggests that they are indistinguishable from normal embryonic stem cells.

"Patients are so interested in this procedure, and we are confident enough in its feasibility, that we have been willing to store eggs for use as soon as safety and effectiveness are shown,” said Jerry Hall of the Institute for Reproductive Medicine and Genetics (Los Angeles, CA, USA; www.preimplantationgenetictesting.com). However, much work still has to be done to ensure that any tissues made from parthenogenetic stem cells are absolutely normal.

New
Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
HPV Molecular Test
BD Onclarity HPV Assay
New
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.